Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Anderson

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Neurology|October 29, 2025
Integrative Deep Learning of Genomic and Clinical Data for Predicting Treatment Response in Newly Diagnosed EpilepsyWei Feng, Duong Nhu, Alison Anderson, et al.
Frontiers in Immunology|July 11, 2026
Immunological and molecular signatures of carbamazepine-induced maculopapular exanthemaKerry A Mullan, Stephanie Davies, Kimberley Teoh, et al.
Elife|March 9, 2023
Disease-modifying effects of sodium selenate in a model of drug-resistant, temporal lobe epilepsyPablo M Casillas-Espinosa, Alison Anderson, Anna Harutyunyan, et al.
Annals of Neurology|March 28, 2020
Antiepileptic Drug Teratogenicity and De Novo Genetic Variation LoadPiero Perucca, Alison Anderson, Dana Jazayeri, et al.
Neurology|January 14, 2026
Transcription Factor Binding and Individual Genetic Risk of Valproate TeratogenicityAlison Anderson, Piero Perucca, Elena Vianca, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypesSiwei Chen, Bassel W Abou-Khalil, Zaid Afawi, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Neurology|October 29, 2025
Integrative Deep Learning of Genomic and Clinical Data for Predicting Treatment Response in Newly Diagnosed EpilepsyWei Feng, Duong Nhu, Alison Anderson, et al.
Frontiers in Immunology|July 11, 2026
Immunological and molecular signatures of carbamazepine-induced maculopapular exanthemaKerry A Mullan, Stephanie Davies, Kimberley Teoh, et al.
Elife|March 9, 2023
Disease-modifying effects of sodium selenate in a model of drug-resistant, temporal lobe epilepsyPablo M Casillas-Espinosa, Alison Anderson, Anna Harutyunyan, et al.
Annals of Neurology|March 28, 2020
Antiepileptic Drug Teratogenicity and De Novo Genetic Variation LoadPiero Perucca, Alison Anderson, Dana Jazayeri, et al.
Neurology|January 14, 2026
Transcription Factor Binding and Individual Genetic Risk of Valproate TeratogenicityAlison Anderson, Piero Perucca, Elena Vianca, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypesSiwei Chen, Bassel W Abou-Khalil, Zaid Afawi, et al.
Pageof 4